Clinical presentation of abdominal tuberculosis in HIV seronegative adults by Bolukbas, Cengiz et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Gastroenterology
Open Access Research article
Clinical presentation of abdominal tuberculosis in HIV seronegative 
adults
Cengiz Bolukbas*1, Fusun F Bolukbas1, Tulin Kendir2, Remzi A Dalay2, 
Nihat Akbayir3, Mehmet H Sokmen3, Ali T Ince2, Mithat Guran4, 
Erkan Ceylan5, Guray Kilic6 and Oya Ovunc2
Address: 1Department of Internal Medicine, Gastroenterology Division, Faculty of Medicine, Harran University, Sanliurfa, Turkey, 
2Gastroenterology Clinic, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey, 3Gastroenterology Clinic, Sisli Etfal Training and 
Research Hospital, Istanbul, Turkey, 4General Surgery Clinic, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey, 5Department 
of Chest Diseases, Faculty of Medicine, Harran University, Sanliurfa, Turkey and 6Pathology Unit, Haydarpasa Numune Training and Research 
Hospital, Istanbul, Turkey
Email: Cengiz Bolukbas* - drcengizbolukbas@hotmail.com; Fusun F Bolukbas - fusunbol@yahoo.ca; Tulin Kendir - eylul19@hotmail.com; 
Remzi A Dalay - remzidalay@att.net; Nihat Akbayir - akbayirn@hotmail.com; Meh m e tHS o k m e n-h m s o k m e n @ h o t m a i l . c o m ;  
Ali T Ince - alince@superonline.com; Mithat Guran - mithatguran@yahoo.com; Erkan Ceylan - drerkanceylan@yahoo.com; 
Guray Kilic - gurayk61@hotmail.com; Oya Ovunc - oyaovunc@hotmail.com
* Corresponding author    
Abstract
Background: The accurate diagnosis of abdominal tuberculosis usually takes a long time and requires a high
index of suspicion in clinic practice. Eighty-eight immune-competent patients with abdominal tuberculosis were
grouped according to symptoms at presentation and followed prospectively in order to investigate the effect of
symptomatic presentation on clinical diagnosis and prognosis.
Methods: Based upon the clinical presentation, the patients were divided into groups such as non-specific
abdominal pain & less prominent in bowel habit, ascites, alteration in bowel habit, acute abdomen and others.
Demographic, clinical and laboratory features, coexistence of pulmonary tuberculosis, diagnostic procedures,
definitive diagnostic tests, need for surgical therapy, and response to treatment were assessed in each group.
Results: According to clinical presentation, five groups were constituted as non-specific abdominal pain (n = 24),
ascites (n = 24), bowel habit alteration (n = 22), acute abdomen (n = 9) and others (n = 9). Patients presenting
with acute abdomen had significantly higher white blood cell counts (p = 0.002) and abnormalities in abdominal
plain radiographs (p = 0.014). Patients presenting with alteration in bowel habit were younger (p = 0.048). The
frequency of colonoscopic abnormalities (7.5%), and need for therapeutic surgery (12.5%) were lower in patients
with ascites, (p = 0.04) and (p = 0.001), respectively. There was no difference in gender, disease duration,
diagnostic modalities, response to treatment, period to initial response, and mortality between groups (p > 0.05).
Gastrointestinal tract alone was the most frequently involved part (38.5%), and this was associated with acid-fast
bacteria in the sputum (p = 0.003).
Conclusion: Gastrointestinal tract involvement is frequent in patients with active pulmonary tuberculosis.
Although different clinical presentations of patients with abdominal tuberculosis determine diagnostic work up
and need for therapeutic surgery, evidence based diagnosis and consequences of the disease does not change.
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Background
Tuberculosis (TB) is rarely seen in western countries, but
it is not an uncommon disease in the developing world
[1]. Its reappearance has increased in association with the
acquired immunodeficiency syndrome (AIDS) and immi-
gration to the United States [2-4]. TB in its various forms
remains an important cause of morbidity and mortality in
developing countries and in patients with AIDS [5].
Recently, along with the increased incidence of TB,
extrapulmonary TB incidence has also increased [6,7]. The
occurrence of abdominal TB is independent of pulmonary
disease in most patients, with a reported incidence of
coexisting disease varying from 5 to 36% [8]. In patients
with abdominal TB, the highest incidence of disease was
noted in the gastrointestinal tract and in the peritoneum,
followed by the mesenteric lymph nodes. Within the gas-
trointestinal tract, the ileocecal area is the most common
site of involvement [9].
In general, upper gastrointestinal (GI), hepatic and pan-
creatic involvements are rare in autopsy series and case
reports [10-12].
Because of chronic and nonspecific clinical and radiolog-
ical findings mimicking several diseases, such as Crohn's
disease, carcinoma, sarcoma [13], amebiasis, yersinia
infection, gastrointestinal histoplasmosis, and periappen-
diceal abscess [9], the diagnosis of the abdominal TB
requires a high index of suspicion and, despite using
newly developed diagnostic tools, it usually takes a long
time to get accurate diagnosis in clinic practice. The
patients' subjective complaints on admission should
guide the diagnostic procedures [14].
In this report, the effect of different clinical presentations
of abdominal TB on clinical course, diagnosis and out-
come of the disease in 88 immune-competent patients
who were grouped according to the gastrointestinal symp-
toms at admission and followed prospectively between
1995 and 2004.
Methods
Patients, who were suspected to have abdominal tubercu-
losis through symptoms and / or operative findings, were
prospectively evaluated. In addition to physical examina-
tion, basic laboratory studies, and anti-human immuno-
deficiency virus (HIV) serology, patients admitted with
abdominal symptoms including pain, distension, nausea,
vomiting, altered bowel habit, weight loss were evaluated
for tuberculosis. Previous and family histories of TB were
asked; chest X-ray, abdominal plain graph, tuberculin skin
test and abdominal ultrasound (US) were routinely
obtained during a nine-year period between 1995–2004.
In case of suggestion of pulmonary TB in chest x-ray (infil-
tration or consolidation, nodularity, calcification, cavitary
lesion, and fibrocalcific scar in lung parenchyma, pleural
effusion, hilar or mediastinal lymphadenopathy), acid-
fast bacilli (AFB) was searched in sputum and/or gastric
juice. Sputum culture, and computed tomography (CT) of
thorax were obtained. In case of negative results, bron-
choscopy, and bronchoalveolar lavage plus biopsy were
performed. If there was mediastinal lymphadenopathy
(LAP) and the exact diagnosis could not be established by
other means, mediastinoscopy with LAP biopsy was
performed.
Based upon the clinical presentation, the patients were
divided into five groups to guide diagnostic evaluations.
Group I: Patients with non-specific abdominal pain
Group II: Patients with ascites
Group III: Alteration in bowel habit (diarrhea, constipa-
tion or together)
Group IV: Acute Abdomen
Group V: Others (jaundice, dysphagia, fistula, fever of
unknown origin, mass, weight loss)
Group I patients: abdominal CT, and according to the
findings of CT, fine needle aspiration (FNA) biopsy or
laparoscopy, upper and lower GI system endoscopy, and
endoscopic biopsy for microbiologic and histopathologic
diagnosis if a lesion seen.
Group II patients: ascitic cell count and type of cells, bio-
chemistry analysis, smear for AFB, culture, IS6110-based
in-house polymerase chain reaction (PCR) protocol for
mycobacterium tuberculosis, and cytologic examination
of ascitic fluid and abdominal CT.
Group III patients: colonoscopy and small bowel series,
stool culture and AFB in stool if diarrhea present. Endo-
scopic biopsy for histopathologic examination and tissue
culture and PCR for M. tuberculosis. Abdominal CT, and
US. If ascites found, the exaimations in group II.
Group IV patients: histopathologic examination of surgi-
cal specimen if laparotomy performed. Abdominal CT,
and colonoscopy if the patient is conservatively observed.
Group V patients: Upper endoscopy and thoraco-abdom-
inal CT if dysphagia is present. Liver biopsy after exclud-
ing other causes if jaundice is present. Abdominal CT and
if necessary MR and FNA in cases with abdominal mass
were done. In patients with fistula only, AFB, culture and
PCR of flux material; fistulography, CT, barium series orBMC Gastroenterology 2005, 5:21 http://www.biomedcentral.com/1471-230X/5/21
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endoscopic examinations are performed to find out fistula
tract.
Intraabdominal fluid (free or loculated; clear or complex
with septae or debri), inter loop ascitis such as 'club sand-
wich' or 'sliced bread' signs which are due to localized
fluid between radially oriented bowel loops, due to local
exudation from the inflammed bowel, lymphadenopathy
(discrete or conglomerated), bowel wall thickening and
pseudo kidney sign were attributed to abdominal TB in
abdominal US [15,16]. CT findings include adenopathy
with low-density in centers, splenomegaly and hepatome-
galy with nodules, ascites with complex features, bowel
involvement, pleural effusion, intrasplenic, intrahepatic
and intrapancreatic masses [8]. The colonoscopic features
were defined as ulcers, nodules, deformed cecum and ile-
ocecal valve, strictures, multiple fibrous bands and poly-
poid lesions [17].
Definitive diagnosis was based on one of the following
methods with certain criteria: First of all, diagnostic prior-
ity for TB was given to show AFB microbiologically by cul-
ture or by both smear and PCR positivities, if that was not
possible, the presence of caseating granulomatous lesions
in the tissue was accepted as histopathological diagnosis
of TB. If the diagnosis of TB was not obtained by using
both of these methods, we achieved a clinical diagnosis of
TB after a successful empiric therapeutic trial [9,18].
Empiric therapeutic trial was conducted for at least for 3
months with standard four drugs regiment (isonicotinic
acid hydrazide, rifampin, pyrazinamide and ethambutol
or streptomycin).
The following features were determined within each
patient group: age, gender, disease duration, symptom fre-
quency, TB presence in patient's history or environment,
coexistence with pulmonary TB, tuberculin skin test sta-
tus, laboratory findings, diseased segment within gas-
trointestinal segment, necessary diagnostic work-up, exact
diagnosis methods, need for surgery except acute abdo-
men, response to therapy. The patients were followed up
for adverse effects of medical treatment and surgical
complications.
Numeric values were determined as percent or mean ± SD.
Non-parametric Kruskal-Wallis test was used for quantita-
tive results and chi-square test was used for qualitative
results between groups. P value of less than 0.05 was con-
sidered to indicate the statistical significance.
Table 1: Demographic and clinic features in whole group.
Patients, (n) 88
Age (year) 31.4 ± 15
Gender (F/M) 48/40
Disease duration (month) 10.4 ± 19
Main symptom (n/%)
Abdominal pain 25 (28.4%)
Abdominal distension 23 (26.1%)
Diarrhea 15 (17%)
Fever 4 (4.5%)
Weight loss 4 (4.5%)
Ileus 4 (4.5%)
Perforation 4 (4.5%)
Others 4 (4.5%)
Dysphagia 2 (2.3%)
Icter 2 (2.3%)
Dyspepsia 1 (1.1%)
Previous history for TB 15 (17%)
Family history for TB 8 (9.1%)
F, Female; M, Male; TB, Tuberculosis.
Table 2: The results of the diagnostic methods in whole group.
ESR (mm/h) 68 ± 24
CRP (mg/L) 53 ± 39
WBC (/mm3 × 1000) 9.2 ± 3.6
Hct % 32.3 ± 5.2
Hb (g/dL) 10.6 ± 1.9
Chest X-ray %
Active lesion 24 (27.3%)
Lesion consistent with prior TB 15 (17%)
Normal 49 (55.7%)
AFB positivity in sputum % 11 (12.6%)
Lesion frequency in abdominal 
plain graphs %
21 (23.9%)
Abdominal US abnormality* 78 (88.6%)
*Including hepatomegaly-splenomegaly
ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; WBC, 
white blood cell count;
Hct, haemotocrit; Hb, haemoglobin; AFB, acid-fast bacteria; US, 
ultrasonography.BMC Gastroenterology 2005, 5:21 http://www.biomedcentral.com/1471-230X/5/21
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Results
After extensive clinical, endoscopic, radiologic, microbio-
logic and histopathologic investigation, we identified and
followed 88 abdominal TB cases with gastrointestinal
involvement. Age, gender, and symptoms on admission
are summarized in Table 1; laboratory, chest X-ray,
abdominal plain film and US findings are summarized in
Table 2.
The most frequent symptom was abdominal pain
(28.4%). TB was present in patient history and environ-
ment in 17 and 9.1 percent, respectively. Ascites was the
most frequent physical finding (35.2%). Other physical
examination findings were hepatomegaly (22.7%),
splenomegaly (17%), abdominal mass (17%), fistula
(12.5%), peripheral LAP (11.4%) and acute abdomen
(10.2%). Most of the patients were significantly anemic.
Erythrocyte sedimentation rate (ESR) and C-reactive pro-
tein (CRP) were mostly elevated in the study group. ESR
was normal only in 4 cases (4.5%). Pulmonary active
lesion or lesion consistent with prior TB were detected in
27.3 and 17 percent of the patients, respectively. There
was significant association between AFB in sputum and
GIS tract disease (p = 0.003). Ascites was detected in
40.9% of patients on US. On abdominal CT, besides
ascites, gut wall thickness (frequently ileocecal region),
LAP, abscess, and organomegaly etc. were detected in
81.8%.
According to clinical presentation, five groups were con-
stituted as non-specific abdominal pain (n = 24), ascites
(n = 24), alteration in bowel habit (n = 22), acute abdo-
men (n = 9), and others (n = 9). Age, gender, symptoms,
need for surgery, diagnostic tests, how the diagnosis estab-
lished (tissue and culture based against empiric), response
to therapy according to the groups on admission are sum-
marized in Table 3 and Table 4. With excluding grouping
symptoms, mean white blood cell count (WBC) and
lesion frequency in plain abdomen graphy were higher in
patients admitting with acute abdomen (p = 0.002 and p
= 0.014, respectively). Patients with alteration in bowel
habit were statistically younger (p = 0.048). Abnormal
finding frequency on abdominal CT was equal between
groups (p = 0.196). CT guided FNA biopsy was preformed
in 10 patients and its diagnostic yield was 70% in these
patients. Colonoscopic lesion frequency was the lowest
(7.5%) in colonoscopy-performed patients with ascites (p
= 0.04). In our patients who had colonoscopic abnormal-
ities, tissue culture and PCR positivity for TB was 11.1%
and 19.2%, respectively. Although need for surgery rates
was not different between patient groups, therapeutic sur-
gery rate was significantly low (12.5%) in patients with
ascites (p = 0.001). Gender, disease duration, associated
symptoms, definitive diagnostic methods, response to
therapy, time to response to therapy, and mortality were
not different between groups (p > 0.05).
The localization and the type of disease were shown in
Table 5. Gastrointestinal tract alone was the most frequent
diseased part (38.5%) and iloececal region was the pre-
ferred area (53.8%) in the tract. Peritoneal and GI tract
involvement proportions were approximately equal in
patients admitted with abdominal pain. Isolated involve-
ment of peritoneum was 71% in patients with ascites. The
involvement rate of GI tract alone was 72.7% in patients
with alteration in bowel habit. All patients with acute
abdomen had GI tract involvement. Solitary mesenteric
Table 3: Demographic and clinical features in divided groups based upon the clinical presentation.
Groups* I (n = 24) II (n = 24) III (n = 22) IV (n = 9) V (n = 9) P
Age (yr) 36.5 ± 20 30.4 ± 13 23.5 ± 8 32.7 ± 12 38 ± 16 0.048
Gender (F/M) 12/12 13/11 14/8 2/7 5/4 0.34
Disease Duration (mo) 11.3 ± 23 6 ± 8 9.8 ± 14 25 ± 41 6.6 ± 5 0.869
Previous history of TB % 16.7 8.3 18.2 22.2 33.3 0.530
Family history for TB % 8.3 4.2 18.2 11.1 0 0.425
Weight loss (kg) 8.2 ± 7 6 ± 4.5 8.5 ± 6 8.7 ± 5 8.1 ± 7.2 0.496
Temperature (°C) 37.5 ± 1 37.4 ± 0.8 37.5 ± 1 37.9 ± 0.9 37.2 ± 1 0.615
Fistula (%)* 8.3 0 31.8 0 22.2 0.07
Therapeutic Operation % 33.3 12.5 27.3 66.6 22.2 0.001
Response to therapy % 91.7 95.8 90.9 77.7 100 0.354
First response to therapy (mo) 2.5 ± 1.5 2.1 ± 1.6 1.9 ± 1.3 2.6 ± 1.5 2.8 ± 2 0.298
Death % 8.3 4.2 4.5 11.1 0 0.825
*Group I, non-specific abdominal pain; Group II, ascites; Group III, alteration in bowel habit (diarrhea, constipation or together); Group IV, acute 
abdomen; Group V, others (jaundice, dysphagia, fistula, fever of unknown origin, mass, weight loss);
Yr, year; F, female; M, male; Mo, month; TB, tuberculosis.
P value of less than 0.05 was considered to indicate the statistical significance in between groups.BMC Gastroenterology 2005, 5:21 http://www.biomedcentral.com/1471-230X/5/21
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lymphadenitis (0.5%), liver (0.5%), pancreas (0.5%) and
esophagus (0.5%) involvements were established.
In the whole group, tissue and culture based and empiric
therapeutic trial diagnosis rates were 75.4 and 14.6 per-
cent, respectively.
Peroperative mortality in 1 case, fistula in 3 cases, short
bowel in 1 case, and chronic pancreatic insufficiency in 1
patient developed as complications.
Discussion
Patients with abdominal TB may have many symptoms
and mimic many diseases, therefore if it is not clinically
suspected, it may result in important morbidity and mor-
tality. In abdominal TB series GI tract and peritoneum are
reported as the most frequent sites of involvement [9].
Four major pathophysiologic mechanisms are proposed
for abdominal TB: hematogenous spread, swallowing of
infected sputum, ingestion of contaminated milk or food,
and contiguous spread from adjacent organs [19].
In our patients, GI tract alone, peritoneum alone, and GI
tract with peritoneum involvement (multi-site) were most
frequent and detected in 38.5, 28, and 20.4 percent,
respectively. Mesenteric lymph node involvement alone
was rare, liver involvement was uncommon, but even
esophageal and pancreatic involvement mimicking tumor
was present.
The ileocecal area is the most frequent site of involvement
in the GI tract [9,20]. Physiologic stasis, absorption of
digested materials, and augmented lymphoid tissue at ile-
ocecal area may be the causes of this property [21,22]. In
our patients, GI tract and ileocecal region in particular,
was also most frequently diseased part.
Gastroenterological symptoms of abdominal TB depend
on the organ or tissue involved. Abdominal pain, tense-
Table 4: The results of the diagnostic laboratory methods, the rate of abnormality in imaging and invasive methods, and definitive 
diagnosis in divided groups based upon the clinical presentation.
Groups* I (n = 24) II (n = 24) III (n = 22) IV (n = 9) V (n = 9) P
WBC (/mm3 × 1000) 10 ± 4 8.7 ± 2.6 7.7 ± 1.8 14 ± 3.7 7.3 ± 2.8 0.002
ESR(mm/h) 67 ± 21 65 ± 31 71 ± 20 69 ± 21 72 ± 26 0.842
Tuberculin skin test (mm) 17 ± 7 18 ± 6.5 13 ± 7 18 ± 11 16 ± 9 0.119
AFB in sputum % 12.5 4.5 18.2 25 11 0.602
Chest X-ray % 54.2 27.5 40.9 66.6 22.2 0.448
APG % 20.8 12.5 31.8 66.7 0 0.014
Abdominal CT % 91.7 100 90.9 100 77.8 0.196
** Colonoscopy % 62.5 (5/8) 7.5 (2/15) 90.9 (20/22) 75 (3/4) 33.3 (1/3) 0.04
Operation % 54.2 54.2 33.3 75 22.2 0.156
Diagnosis %
Evidence based 79.2 83.3 86.4 88.9 88.9
Histopathologic 62.5 50 45.5 44.4 55.6
Microbiologic 4.2 12.5 9.1 33.3 11.1 0.933
H+M 12.5 20.8 31.8 11.1 22.2
ETT% 20.8 16.7 13.6 11.1 11.1
*Group I, non-specific abdominal pain; Group II, ascites; Group III, alteration in bowel habit (diarrhea or constipation or together); Group IV, acute 
abdomen; Group V, others (jaundice, dysphagia, fistula, fever of unknown origin, mass, weight loss);
** The percent in patients with colonoscopy performed WBC, white blood cell count; ESR, erythrocyte sedimentation rate; AFB, acid-fast bacteria; 
APG, abdominal plain graphy; CT, computed tomography; H, histopathologic; M, microbiologic; ETT, empiric therapeutic trial. P value of less than 
0.05 was considered to indicate the statistical significance in between groups.BMC Gastroenterology 2005, 5:21 http://www.biomedcentral.com/1471-230X/5/21
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ness, and diarrhea, as our patients demonstrated, are fre-
quent symptoms. Also, as reported in the literature, active
TB lesion or lesion consistent with prior TB in the lungs
are detected in 27.3 and 17 percent of the whole group of
patients, respectively [9,18]. Diagnosis is difficult in the
absence of pulmonary involvement. As a result, clinical
and radiologic signs of pulmonary TB must be searched
for in every patient even in the absence of pulmonary
symptoms. Meantime, absence of pulmonary findings
does not rule out abdominal TB.
As reported previously [14], subjective complaints of the
patients could guide the diagnostic procedures. For this
reason, to group the patients according to their symptoms
on admission may cause the diagnostic work up to be
more cost effective. When our patients are grouped
according to symptoms, disease duration, gender, weight
loss, fever, and previous or family history of TB were not
different between groups. There was no significant differ-
ence in frequency of radiologic pulmonary lesions, tuber-
culin skin test status, and ESR or CRP elevation between
groups. This observation has not been reported before.
Although WBC, and abdominal plain film abnormalities
were higher in patients with acute abdomens, these find-
ings were nonspecific for TB diagnosis. On the other
hand, macroscopic findings and histopathologic and
microbiologic investigations of the tissues obtained dur-
ing therapeutic surgery made abdominal TB diagnosis eas-
ier and faster in this specific patient group. Abdominal CT
abnormalities regarding TB were observed in all patients
with acute abdominal findings. This feature has given an
opportunity to follow these patients, excluding those with
perforation, with conservative medical treatment [8,23].
In this subgroup of patients colonoscopy during follow-
up revealed abnormality in 75%, and provided his-
topathologic and microbiologic TB diagnosis in 50%.
Although both abdominal US and CT are equally sensitive
in detecting ascites, CT is superior to US in detecting LAP,
gut wall thickness, omental cake, and other abnormalities
[24,25]. Abnormal abdominal CT findings in our series
were higher than US findings and were equal in each
group. CT shows localization and type of the lesion, but it
is not specific for TB diagnosis [26,27]. CT guides the fol-
lowing diagnostic methods such as FNA, endoscopy,
laparoscopy or laparotomy [16,27].
Therapeutic and diagnostic surgery rates were similar
between our patient groups. This may be due to two rea-
sons. Firstly, ascites examination, FNA biopsy, and endo-
scopic methods may be inadequate for definitive
diagnosis. Secondly, patients with abdominal pain or
altered bowel habit groups may develop complications
requiring surgery. Diagnostic laparotomy was needed
most often in patients with ascites. Infrequent detection of
AFB in ascitic fluid, late results of ascites cultures, and
uncommon culture yield of M. tuberculosis are reasons
Table 5: The distribution of involvement area in the groups*.
Localization Group I 
(n = 24)
Group II 
(n = 24)
Group III 
(n = 22)
Group IV 
(n = 9)
Group V 
(n = 9)
Total 
(n)
Multiple (n) (Peritoneum, SB, colon, pericardium) 2 7 6 1 2 18
GI Tract (n) 34
SB 3 2 1
Ileocecal 6 7 5
Colon 6 1
Stomach 1
Esophagus 2
Liver 3 1 4
Peritoneum 8 17 25
Mesenteric LAP 3 2 5
Pancreas and biliary system 1 1 2
Total (n) 24 24 22 9 9 88
*Group I, non-specific abdominal pain; Group II, ascites; Group III, alteration in bowel habit (diarrhea or constipation or together); Group IV, acute 
abdomen; Group V, others (jaundice, dysphagia, fistula, fever of unknown origin, mass, weight loss);
SB, small bowel; GI, gastrointestinal; LAP, lymphadenopathyBMC Gastroenterology 2005, 5:21 http://www.biomedcentral.com/1471-230X/5/21
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for increased laparoscopy/laparotomy need [28,29]. Diag-
nostic operation was lower in patients with alteration in
bowel habit and the group in which GI tract was not
directly involved. Endoscopic examinations increased
diagnostic efficiency and decreased diagnostic surgical
interventions in patients with alteration in bowel habit.
Patients with acute abdominal symptoms frequently have
GI tract and particularly ileocolonic involvement. Colon-
oscopy is effective to establish TB diagnosis in patients
that could be managed medically in this group. Colonos-
copy provides tissue for culture, PCR and histopathologic
examination [30]. In our patients who had colonoscopic
abnormalities, tissue culture and PCR positivity for TB
rate was lower than or at most equal to previously
reported series [17,31,32]. Low colonoscopic biopsy
count and sample size may affect this result. Stool
examination for AFB and culture for TB are proposed in
the literature, but the association of GI TB with AFB in the
sputum may cause misinterpretation [19].
AFB is searched for in the sputum and when necessary in
gastric juice in our patients with pulmonary involvement.
There was a positive association between AFB positivity in
sputum and GI tract involvement. This association can be
explained with swallowing infected sputum [19]. AFB in
sputum rate was not different between groups; this can be
explained by existence of GI tract involved patients in
groups formed with patient symptomatology. Patients
with alteration in bowel habit were younger as reported in
the literature. Wig K and et al. reported that the maximum
age incidence of intestinal tuberculosis was also 15 to 24
years [33]. The reason of the high incidence rate of intes-
tinal tuberculosis in young population could be related to
Peyer's patches which play a major role in intestinal
immunity and are portals of entry for significant patho-
gens. Peyer's patches in the small intestine peaks at ages
15–25 and then declines with age [34].
There was no significant difference between evidence
based diagnosis and response to therapy diagnosis in all
groups.
Our diagnosis rate based on response to therapy was sim-
ilar to the rates reported before [18]. There was no differ-
ence in evidence based and response to treatment
diagnosis between our groups. There was also no differ-
ence in first response time to therapy between two diag-
nostic methods. Empiric therapeutic trial appears to be a
useful method for rapid presumptive diagnosis and treat-
ment of tuberculosis [35].
It is reported that there is no difference in response or
relapse rates between 9 month and 18 month treatment
times [36]. All our patients received therapy for 9 months
and had a high cure rate. High cure and low relapse rates
may be caused by immune competence of our patients
and infrequency of primary drug resistance in this group.
High adherence to therapy rate and low adverse effects of
drugs to lower dose rate may influence secondary drug
resistance.
Fistula, short bowel syndrome, and anastomosis leak are
frequent complications of surgery performed in abdomi-
nal TB [37]. Our patients had similar complications.
Conclusion
Gastrointestinal tract involvement is frequent in patients
with active pulmonary tuberculosis. Different clinical
presentation of patients with abdominal TB involving GI
system may determine the necessity of diagnostic or ther-
apeutic surgical interventions, but evidence based diagno-
sis and prognosis are not influenced.
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